Journal of Neurology Neurosurgery and Psychiatry

Article	Citations
Parkinson’s disease: etiopathogenesis and treatment	479
Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials	257
Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management	224
TDP-43 proteinopathies: a new wave of neurodegenerative diseases	168
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions	118
Psychological impact on women health workers involved in COVID-19 outbreak in Wuhan: a cross-sectional study	113
Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic	110
Pattern of cognitive deficits in severe COVID-19	100
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3	97
Diagnostic and prognostic value of serum NfL and p-Tau181in frontotemporal lobar degeneration	92
The future of neuroprotection in stroke	89
Clinical spectrum of high-titre GAD65 antibodies	82
Postinfectious brainstem encephalitis associated with SARS-CoV-2	74
Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer’s disease and mild cognitive impairment: a component network meta-analysis	72
COVID-19–associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network	71
Neuralgic amyotrophy: a paradigm shift in diagnosis and treatment	71
Occupational therapy consensus recommendations for functional neurological disorder	71
Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy	68
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis	68
Diagnostic and therapeutic aspects of hemiplegic migraine	67
Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management	66
Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis	65
Fluid biomarkers in frontotemporal dementia: past, present and future	64
Decade of progress in motor functional neurological disorder: continuing the momentum	63
Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study	62

Advances in the management of glioblastoma	61
Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank	60
Defining causality in COVID-19 and neurological disorders	58
Cerebral microbleeds: from depiction to interpretation	58
Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia	56
Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features	56
Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer’s disease: a focused review on recent advances	55
Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK	55
Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS	54
Management of functional communication, swallowing, cough and related disorders: consensus recommendations for speech and language therapy	54
Performance validity test failure in clinical populations—a systematic review	54
LGI1 antibody encephalitis: acute treatment comparisons and outcome	51
Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key eme	50
Clinical trials in REM sleep behavioural disorder: challenges and opportunities	50
Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders	49
Systematic review of psychotherapy for adults with functional neurological disorder	48
Untargeted metabolomics yields insight into ALS disease mechanisms	48
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis	47
A case of limbic encephalitis associated with asymptomatic COVID-19 infection	47
Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial	46
Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study	45
Retinal imaging in Alzheimer’s disease	44
Wilson’s disease: update on pathogenesis, biomarkers and treatments	44
Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app	44
NOTCH3 variants are more common than expected in the general population and associated with stroke and vascular dementia: an analysis of 200 000 participants	43
Misdiagnosis of prolonged psychogenic non-epileptic seizures as status epilepticus: epidemiology and associated risks	42
Functional movement disorder gender, age and phenotype study: a systematic review and individual patient meta-analysis of 4905 cases	42
Comparison between deep brain stimulation and magnetic resonance-guided focused ultrasound in the treatment of essential tremor: a systematic review and pooled analysis of functional outcomes	42
Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS	41
Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis	41
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial	40
Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers—a developmental disorder	40
Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study	39
Neuroinflammation predicts disease progression in progressive supranuclear palsy	39
Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine	39
Understanding the relationship between cognitive performance and function in daily life after traumatic brain injury	39
Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients	38
Efficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: systematic review and meta-analysis	38
Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder	37
A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson’s disease: results at the 36-month follow-up	37
Systematic clinical approach for diagnosing upper limb tremor	37
Frailty, lifestyle, genetics and dementia risk	36
Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis	36
Multimodal MRI for MRgFUS in essential tremor: post-treatment radiological markers of clinical outcome	36
Mental health and suicide in former professional soccer players	36
Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis	36
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease	35
Effects of TPH2 gene variation and childhood trauma on the clinical and circuit-level phenotype of functional movement disorders	35
Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation	35
Responsive neurostimulation of the thalamus improves seizure control in idiopathic generalised epilepsy: initial case series	35

In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer’s disease	35
Clinical features ofNOTCH2NLC-related neuronal intranuclear inclusion disease	34
Genotype-associated cerebellar profiles in ALS: focal cerebellar pathology and cerebro-cerebellar connectivity alterations	33
Bilateral staged magnetic resonance-guided focused ultrasound thalamotomy for the treatment of essential tremor: a case series study	33
Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register	33
Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersen	33
Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies	32
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias	32
Carotid web: an occult mechanism of embolic stroke	31
Suggestibility in functional neurological disorder: a meta-analysis	31
Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study	31
Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions	31
Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition	31
Early clinical surrogates for outcome prediction after stroke thrombectomy in daily clinical practice	31
Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits	30
Real-life survey of pitfalls and successes of precision medicine in genetic epilepsies	29
Early lowering of blood pressure after acute intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data	29
Intracranial arterial stenosis in Caucasian versus Chinese patients with TIA and minor stroke: two contemporaneous cohorts and a systematic review	29
Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer’s disease	29
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis	29
Neuropathology and emerging biomarkers in corticobasal syndrome	29
Impact of mobile stroke units	28
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations	28
Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA)	28
Lacunar stroke: mechanisms and therapeutic implications	27
Prognostic predictors relevant to end-of-life palliative care in Parkinson’s disease and related disorders: a systematic review	27
Somatic symptom disorder in patients with post-COVID-19 neurological symptoms: a preliminary report from the somatic study (Somatic Symptom Disorder Triggered by COVID-19)	27
Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis	27
Neurodegenerative disease risk among former international rugby union players	27
Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension	27
Split-hand and split-limb phenomena in amyotrophic lateral sclerosis: pathophysiology, electrophysiology and clinical manifestations	27
Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon	27
Rate of, and risk factors for, white matter hyperintensity growth: a systematic review and meta-analysis with implications for clinical trial design	27
Ischaemic stroke associated with COVID-19 and racial outcome disparity in North America	27
Long-term trajectories of decline in cognition and daily functioning before and after stroke	27
Defining functional brain networks underlying obsessive–compulsive disorder (OCD) using treatment-induced neuroimaging changes: a systematic review of the literature	27
RFC1-related ataxia is a mimic of early multiple system atrophy	27
Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion	26
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic	26
Long-term functional decline of spontaneous intracerebral haemorrhage survivors	26
Post-traumatic epilepsy in adults: a nationwide register-based study	26
Systematic evaluation of genetic mutations in ALS: a population-based study	26
Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia	26
Prevalence of dementia in ischaemic or mixed stroke populations: systematic review and meta-analysis	26
Cumulative health deficits, APOE genotype, and risk for later-life mild cognitive impairment and dementia	25
Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration	25
Factors associated with time to independent walking recovery post-stroke	25
Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS	25
Deep brain stimulation of the subthalamic nucleus in obsessive–compulsives disorders: long-term follow-up of an open, prospective, observational cohort	25
Computerised patient-specific prediction of the recovery profile of upper limb capacity within stroke services: the next step	25
Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis	25
Association of obesity with disease outcome in multiple sclerosis	25
GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance	25
Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants	25
Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis	25
Functional disorders after COVID-19 vaccine fuel vaccination hesitancy	25
Quality of life in isolated dystonia: non-motor manifestations matter	25
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy	24
Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects	24
Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study	24
Comorbidity of long COVID and psychiatric disorders after a hospitalisation for COVID-19: a cross-sectional study	24
Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications	24
Pattern of paresis in ALS is consistent with the physiology of the corticomotoneuronal projections to different muscle groups	24
Fronto-striatal circuits for cognitive flexibility in far from onset Huntington’s disease: evidence from the Young Adult Study	24
Management of patients with generalised myasthenia gravis and COVID-19: four case reports	24
IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality	24
Cognitive reserve in amyotrophic lateral sclerosis (ALS): a population-based longitudinal study	24
Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes	23
In vivo PET imaging of neuroinflammation in familial frontotemporal dementia	23
Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology	23
Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis	23
Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis	23
Anti-Aβ agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis	23
Sex differences for phenotype in pathologically defined dementia with Lewy bodies	23
Circadian rhythm of ischaemic core progression in human stroke	23
COVID-19 impact on consecutive neurological patients admitted to the emergency department	23
Making sense of phantom limb pain	23
Relationship between intensity and recovery in post-stroke rehabilitation: a retrospective analysis	22
Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome	22
Antiglycolipid antibodies in Guillain-Barré and Fisher syndromes: discovery, current status and future perspective	22

Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19	22
Electrical stimulation for seizure induction during SEEG exploration: a useful predictor of postoperative seizure recurrence?	22
Concussion symptomology and recovery in children and adolescents with pre-existing anxiety	22
Ischaemic stroke in anticoagulated patients with atrial fibrillation	22
Longitudinal changes of spinal cord grey and white matter following spinal cord injury	21
Apathy, but not depression, predicts all-cause dementia in cerebral small vessel disease	21
Biomarkers in functional movement disorders: a systematic review	21
Medical treatment of SUNCT and SUNA: a prospective open-label study including single-arm meta-analysis	21
Neurite density explains cortical T1-weighted/T2-weighted ratio in multiple sclerosis	21
Diffusion imaging in Huntington’s disease: comprehensive review	21
Comparison of efficacy of deep brain stimulation and focused ultrasound in parkinsonian tremor: a systematic review and network meta-analysis	21
Prevalence, predictors and prognosis of incidental intracranial aneurysms in patients with suspected TIA and minor stroke: a population-based study and systematic review	21
Antiganglioside antibodies in Guillain-Barré syndrome associated with SARS-CoV-2 infection	20
APOE ɛ4dose associates with increased brain iron and β-amyloid via blood–brain barrier dysfunction	20
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS	20
Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab	20
New classification of autoimmune neuropathies based on target antigens and involved domains of myelinated fibres	20
What is brain fog?	20
Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis	20
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod	20
Adoption of focused ultrasound thalamotomy for essential tremor: why so much fuss about FUS?	20
Self-injurious behaviour in movement disorders: systematic review	20
Distinct latent profiles based on neurobehavioural, physical and psychosocial functioning of former National Football League (NFL) players: an NFL-LONG Study	20
Eculizumab versus rituximab in generalised myasthenia gravis	20
Tau-PET imaging predicts cognitive decline and brain atrophy progression in early Alzheimer’s disease	20
Chronic inflammatory demyelinating polyneuropathy associated with diabetes: a European multicentre comparative reappraisal	20
Genotype–phenotype correlations in valosin-containing protein disease: a retrospective muticentre study	19
Frequency of MOG-IgG in cerebrospinal fluid versus serum	19
Acute ischaemic stroke associated with SARS-CoV-2 infection in North America	19
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study	19
Myelin oligodendrocyte glycoprotein-associated disorders are associated with HLA subtypes in a Chinese paediatric-onset cohort	19
Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs	19
Epilepsy, an orphan disorder within the neurodevelopmental family	19
Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants	18
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis	18
Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer’s disease: an observational clinical study	18
The Impact of Traumatic Brain Injury on Neurocognitive Outcomes in Children: a Systematic Review and Meta-Analysis	18
Risk factors for cognitive impairment in amyotrophic lateral sclerosis: a systematic review and meta-analysis	18
Plasma biomarkers for Alzheimer’s disease: a field-test in a memory clinic	17
Structural and functional changes in the retina in Parkinson’s disease	17
Great expectations: virus-mediated gene therapy in neurological disorders	17
Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders	17
Data-driven evolution of neurosurgical gene therapy delivery in Parkinson’s disease	17
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab	17
Localised increase in regional cerebral perfusion in patients with visual snow syndrome: a pseudo-continuous arterial spin labelling study	17
Predicting loss of independence and mortality in frontotemporal lobar degeneration syndromes	17
Multidisciplinary consensus guideline for the diagnosis and management of spontaneous intracranial hypotension	17
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study	17
Plasma GFAP in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study	17
Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial	17
De novo mutations in SOD1 are a cause of ALS	17
Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer’s disease	16
Quantitative effect of sex on disease activity and disability accumulation in multiple sclerosis	16
Tissue bridges predict neuropathic pain emergence after spinal cord injury	16
Functional (psychogenic non-epileptic/dissociative) seizures: why and how?	16
Subjective cognitive complaints at age 70: associations with amyloid and mental health	16
Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis	16
Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder	16
Two-year efficacy and safety of erenumab in participants with episodic migraine and 2–4 prior preventive treatment failures: results from the LIBERTY study	16
Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up	16
Cognitive decline and diabetes: a systematic review of the neuropathological correlates accounting for cognition at death	16
Location of intracranial aneurysms is the main factor associated with rupture in the ICAN population	16
Neuromyelitis optica spectrum disorder: pregnancy-related attack and predictive risk factors	16
Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis	16
Neurofilament light chain predicts future dementia risk in cerebral small vessel disease	16
Intravenous thrombolysis for acute ischaemic stroke during COVID‐19 pandemic in Wuhan, China: a multicentre, retrospective cohort study	15
Shift of multiple sclerosis onset towards older age	15
Split hand and motor axonal hyperexcitability in spinal and bulbar muscular atrophy	15
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study	15
CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study	15
Clinical profile of fatal familial insomnia: phenotypic variation in 129 polymorphisms and geographical regions	15
Primary mitochondrial diseases increase susceptibility to bipolar affective disorder	15
Bridging versus direct endovascular therapy in basilar artery occlusion	15
CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer’s disease	15
Favourable arterial, tissue-level and venous collaterals correlate with early neurological improvement after successful thrombectomy treatment of acute ischaemic stroke	15
Nervous system: subclinical target of SARS-CoV-2 infection	15
Prediction of dementia using diffusion tensor MRI measures: the OPTIMAL collaboration	15
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex	15
Expanding the spectrum of VEXAS syndrome: association with acute-onset CIDP	15
Regional hyperperfusion in cognitively normal APOE ε4 allele carriers in mid-life: analysis of ASL pilot data from the PREVENT-Dementia cohort	15
Surgical outcomes between temporal, extratemporal epilepsies and hypothalamic hamartoma: systematic review and meta-analysis of MRI-guided laser interstitial thermal therapy for drug-resistant epileps	14
Early brain biomarkers of post-traumatic seizures: initial report of the multicentre epilepsy bioinformatics study for antiepileptogenic therapy (EpiBioS4Rx) prospective study	14
Effects of 40 Hz transcranial alternating current stimulation (tACS) on cognitive functions of patients with Alzheimer’s disease: a randomised, double-blind, sham-controlled clinical trial	14
Longitudinal observational study investigating outcome measures for clinical trials in inclusion body myositis	14
Anterior limb of the internal capsule tractography: relationship with capsulotomy outcomes in obsessive-compulsive disorder	14
Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson’s disease	14
Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome	14
Predictors of persistent postural-perceptual dizziness (PPPD) and similar forms of chronic dizziness precipitated by peripheral vestibular disorders: a systematic review	14
Early life involvement in C9orf72 repeat expansion carriers	14
Results of the COMPARE trial of Constraint-induced or Multimodality Aphasia Therapy compared with usual care in chronic post-stroke aphasia	14
Efficacy of spoken word comprehension therapy in patients with chronic aphasia: a cross-over randomised controlled trial with structural imaging	14
Pallidal deep brain stimulation in primary Meige syndrome: clinical outcomes and psychiatric features	14
Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: a multicentre Italian study	14
Paraneoplastic cochleovestibulopathy: clinical presentations, oncological and serological associations	13
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring	13